[Asu1,6, Arg8]-Vasopressin

<strong>[Asu1,6,Arg8]-Vasopressin</strong>_x000D_ <strong>Catalog number:</strong> MDP0363_x000D_ <strong>CAS Number: </strong>100929-62-2_x000D_ <strong>Sequence: </strong>cyclo(Tyr-Phe-Gln-Asn-Asu)-Pro-Arg-Gly-NH2 (Asu: L-α-Aminosuberic acid) (Cyclic form between Asu ρEcarboxyl group and Tyr α-amino group)_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight:</strong> 1032.8 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals._x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Sibilia V, Netti C, Guidobono F, Villa I, Pecile A. Inhibitory effects of centrally administered /ASU1-7/eel calcitonin on basal and stimulated prolactin release in rats J Endocrinol Invest. 1990 Jun;13(6):507-11._x000D_ 2: Bramucci M, Singh M, Nagarajan V. Biotransformation of p-xylene and 2,6-dimethylnaphthalene by xylene monooxygenase cloned from a Sphingomonas isolate Appl Microbiol Biotechnol. 2002 Sep;59(6):679-84._x000D_ 3: Fahrenholz F, Tóth G, Crause P, Eggena P, Schwartz IL. [1,6-alpha-aminosuberic acid, 3-(p-azidophenylalanine), 8-arginine] vasopressin: a new photoaffinity label for hydroosmotic hormone receptors. Characterization of the ligand and irreversible stimulation of hydroosmotic water flow in toad bladder by photoaffinity labeling J Biol Chem. 1983 Dec 25;258(24):14861-7._x000D_ 4: Yamaguchi M, Momose K. Effect of calcitonin on fructose 1,6-diphosphatase activity in rat liver: role of cytosolic calcium concentration Horm Metab Res. 1984 Dec;16(12):650-3._x000D_ 5: Minamitani N, Chihara K, Kaji H, Kodama H, Fujita T. Inhibitory effect of [Asu1,7]-eel calcitonin on growth hormone-secretion in conscious, freely moving, male rats Endocrinology. 1985 Jul;117(1):347-53._x000D_ 6: Kaji H, Chihara K, Minamitani N, Kodama H, Kita T, Fujita T. Effect of [Asu1,7]eel calcitonin on prolactin release in normal subjects and patients with prolactinoma Acta Endocrinol (Copenh). 1985 Mar;108(3):297-304._x000D_ 7: Morita T, Yamamoto A, Takakura Y, Hashida M, Sezaki H. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats Pharm Res. 1994 Jun;11(6):909-13._x000D_ 8: Zhang H, Wu C, Chen Q, Chen X, Xu Z, Wu J, Cai D. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models PLoS One. 2013 May 20;8(5):e61477._x000D_ 9: Morimoto S, Miyauchi A, Fukuo K, Imanaka S, Yamamoto H, Tsuchiya H, Koh E, Yukawa S, Onishi T, Avioli LV, et al. Eel calcitonin suppresses plasma human calcitonin levels in medullary carcinoma of the thyroid Clin Sci (Lond). 1986 Apr;70(4):333-8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3833898">10: Clementi G, Prato A, Rapisarda E, Conforto G, Mangano O, Caruso A, Scapagnini U. Inhibition of restraint stress by systemic (Asu1,7) eel-calcitonin J Endocrinol Invest. 1985 Dec;8(6):543-6. </a>_x000D_ _x000D_ <strong>Products Related to [Asu1,6,Arg8]-Vasopressin can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>